What is the difference between a CT scan and a PET scan for Lymphoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
CT Scan vs. PET Scan for Lymphoma
Great question! Both scans are important imaging tools for lymphoma, but they work very differently and provide different information to your care team.
CT Scan (Computed Tomography)
A CT scan uses X-rays and computer technology to create detailed pictures of the inside of your body. According to the NCCN Guidelines for Patients with Marginal Zone Lymphomas, a CT scan takes many X-rays of the same body part from different angles, and all those images are combined to make one detailed picture.
What it shows:
- The size and location of lymph nodes and tumors
- The structure of organs and tissues
- Whether lymph nodes are enlarged (swollen)
- How tumors are positioned relative to other organs
For lymphoma specifically: CT scans are excellent at showing where cancer deposits (tumor locations) are in your body, particularly in the chest, abdomen, and pelvis.
Contrast material: Most CT scans use contrast material—a substance injected into your vein that makes the images clearer. This is not a dye and leaves your body naturally through urine right after the test.
PET Scan (Positron Emission Tomography)
A PET scan uses a radioactive tracer (a special substance injected into your vein) to show how active cancer cells are. According to NCCN Guidelines, the tracer helps identify where cancer cells are in the body and whether they're using sugar to grow. Cancer cells show up as bright spots on PET scans because they typically use more sugar than normal cells.
What it shows:
- Which cells are actively growing (metabolically active)
- Functional activity of tumors—how "busy" they are
- Whether cancer is responding to treatment
- Sometimes detects disease that CT might miss
Important limitations: Not all tumors appear on PET scans, and not all bright spots are cancer. It's normal for the brain, heart, kidneys, and bladder to show up bright. Inflammation or infection can also appear as bright spots.
Key Differences at a Glance
| Feature | CT Scan | PET Scan | |---|---|---| | What it measures | Size, location, structure | Activity level, metabolism | | Technology | X-rays + computer | Radioactive tracer | | Best for | Seeing tumor anatomy | Seeing if tumor is active | | Radiation dose | Moderate X-ray exposure | Small amount of radioactivity |
Why Both Matter for Lymphoma
Your oncology team often uses both scans together because they provide complementary information:
- CT shows the "map" — where the tumors are and how big they are
- PET shows the "activity" — which areas are actively growing cancer
This combination helps your doctors:
- Diagnose lymphoma accurately
- Determine how advanced your disease is (staging)
- Monitor whether treatment is working
- Detect recurrence (cancer returning)
Questions to Ask Your Care Team
Since imaging interpretation is important for your treatment plan, consider asking:
- "Which scans do you recommend for my specific lymphoma type, and why?"
- "Will you be using CT, PET, or both to monitor my treatment response?"
- "How often will I need imaging scans during and after treatment?"
- "What do my specific scan results show about my cancer's location and activity?"
- "Are there any concerns about radiation exposure, and how do the benefits outweigh the risks?"
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: